Printer Friendly

COMPANY INFORMATION
Quest PharmaTech Inc. 9407 20 Ave Edmonton, AB T6N 1E5 Tel: (780) 448-1400 Toll-free: (866) 548-1400 Fax: (780) 416-0324 Contact Name Ragupathy Madiyalakan Industry Pharmaceuticals		Key Executives Ragupathy Madiyalakan, CEO Pierre Vermette, CFO Develops proprietary drugs for the treatment of cancer and dermatological conditions based on a photodynamic and sonodynamic therapy platform.
FP ADVISOR COVERAGE Quest PharmaTech Inc. • FP Corporate Surveys • FP Predecessor & Defunct • Ordering FP Products		TOP INDUSTRY PLAYERS Pharmaceuticals Company Name Revenue ($000s)  Biovail Corporation 807,909 Patheon Inc. 765,812 Cangene Corporation 238,751 Dragon Pharmaceutical, Inc. 162,127 Paladin Labs Inc. 82,744 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 8/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX-VEN/QPT $0.06 $0.13 $0.03 n.a. n.a. n.a. 0.62 Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 10,675 n.a. $-0.00 Oct. 31/09 57.14% -7.72% -24.21% $3,833
ANNUAL FINANCIALS Periods ended: 12m Jan. 31/09 12m Jan. 31/08 12m Jan. 31/07 $000s $000s $000s Operating revenue 2,008 575 2 Net income (204) (1,318) (1,454) Total assets 978 1,611 260 $ $ $ Earnings per share* 0 (0.02) (0.03)   * Common

COMPANY NEWS

Results for 'Quest PharmaTech Inc.' from past 30 days: No hits. (Links are to articles.)